Consider taking a multi-pronged approach to this complex landscape.
Choosing the right CRO has a big impact on product registration and time to market.
How CFDA enforces new regulations is critical to the future.
Targeting this region could expedite your company’s growth.
Companies will soon be able to capitalize on the government’s push to encourage investment in private healthcare facilities.
In lieu of trials, some companies may be able to submit a CER.
Achieving success in India involves patience and a firm grasp on the culture and regulatory environment.
Remember, several basic regulatory approvals are required.
With prices jumping in China, Western device manufacturers and suppliers are looking elsewhere.
Do your due diligence and make sure you have experienced, native boots on the ground.